Stryker (Stryker) Float Percentage Of Total Shares Outstanding : 94.97% (As of Apr. 27, 2024)

View and export this data going back to 1988. Start your Free Trial

What is Stryker Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Stryker's float shares is 361.34 Mil. Stryker's total shares outstanding is 380.47 Mil. Stryker's float percentage of total shares outstanding is 94.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Stryker's Insider Ownership is 1.52%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Stryker's Institutional Ownership is 49.29%.

Stryker Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Stryker's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	361.34	/	380.47
	=	94.97%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker (Stryker) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

SYK:Mexico 1SYK:Italy SYK:Germany SYK:Germany S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Executives

Srikant Datar	director	ICF INTERNATIONAL, INC., 9300 LEE HIGHWAY, FAIRFAX VA 22031
Berry William E Jr	officer: Vice President, Controller	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Kevin Lobo	officer: Group Pres., Neurotech & Spine	STRYKER, 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Allan C. Golston	director	2825 AIRVIEW BLVD., KALAMAZOO MI 49002
Ronda E Stryker	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher	officer: VP, Chief Legal Officer	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
James Andrew Pierce	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Glenn S Boehnlein	officer: Vice President, CFO	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink	officer: VP, Global Human Resources	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio	director	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Timothy J Scannell	officer: Group President	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Roch Doliveux	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Katherine Ann Owen	officer: VP	2825 AIRVIEW BLVD., KALAMAZOO MI 49002